0002105683-26-000001.txt : 20260217 0002105683-26-000001.hdr.sgml : 20260217 20260217110005 ACCESSION NUMBER: 0002105683-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260217 DATE AS OF CHANGE: 20260217 EFFECTIVENESS DATE: 20260217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevate Clinical Research, Inc. CENTRAL INDEX KEY: 0002105683 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573668 FILM NUMBER: 26638083 BUSINESS ADDRESS: STREET 1: 211 E 7TH STREET STREET 2: STE 620 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 832-457-2167 MAIL ADDRESS: STREET 1: 211 E 7TH STREET STREET 2: STE 620 CITY: AUSTIN STATE: TX ZIP: 78701 D 1 primary_doc.xml X0708 D LIVE 0002105683 Elevate Clinical Research, Inc. 211 E 7TH STREET STE 620 AUSTIN TX TEXAS 78701 832-457-2167 DELAWARE None None Corporation true 2024 Devora Henderson 4123 Seneca Drive Beach City TX TEXAS 77523 Executive Officer Director Patrick Feeney 4244 Potomac Avenue Dallas TX TEXAS 75205 Director Other Health Care Decline to Disclose 06b false 2025-06-01 false true false 5000 Indefinite 1000000 Indefinite The total amount sold at the time of filing of this Form D will be no less than the amount indicated above. false 7 0 0 0 false Elevate Clinical Research, Inc. /s/ Devora Henderson Devora Henderson CEO of Issuer 2026-02-17